Essilor awards recognize top independent distributors

Article

Essilor of America has announced the winners of its enhanced Independent Distribution Division Advantage Plan Annual Laboratory Awards.

Key Points

Dallas-Essilor of America has announced the winners of its enhanced Independent Distribution Division (IDD) Advantage Plan Annual Laboratory Awards. The new awards recognize independent distributors that have achieved top sales and marketing performance in specific Essilor product categories. Essilor provides each winning lab with a comprehensive rewards package.

The winners are chosen based on a combination of several key sales-related factors including unit and percentage unit growth, marketing programs and events executed during the year, Advantage Plan programs and promotion results, and partnership with the Essilor Brand sales team.

"Through Advantage Plan, Essilor is committed to providing industry-leading sales and marketing support to help laboratories achieve long-term success," said Bob Colucci, IDD president. "We are proud to honor the achievements of these outstanding labs and look forward to continued partnership."

Recent Videos
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
OptiLIFT in action: Dr. Julie McLaughlin's experience with the new device
© 2025 MJH Life Sciences

All rights reserved.